Clinical Features Associated With Melanoma to Identify Patients at High Risk

A person’s risk factor for melanoma can be used to tailor self-examinations and surveillance programs, says a new study. The incidence of melanoma that occurs on the skin is increasing in predominantly European populations, and Australia's incidence is among the highest in the world.//

Caroline G. Watts, M.P.H., of the University of Sydney, Australia, and coauthors examined clinical features associated with melanomas according to patient risk factors (many moles, history of previous melanoma and family history of melanoma) to improve the identification and treatment of those at higher risk.

Melanoma - Causes, Symptoms, Diagnosis, Treatment & Prevention
Melanoma of the skin is a dangerous type of skin cancer that usually appears as a cancerous mole due to exposure to the sun’s damaging UV rays.

‘Higher-risk patients with many moles are more likely to have melanoma on the trunk, those with a family history may have melanomas on the limbs.’

Tweet it Now

The study included 2,727 patients with melanoma, of whom 1,052 (39 percent) were defined as higher risk because of family history, multiple primary melanomas or many moles. The most common risk factor in this group had many moles, followed by a personal history and a family history.

The authors report the average age at diagnosis was younger for higher-risk patients (62 vs. 65 years) compared with those patients at lower risk because they did not have these risk factors. However, that age differed by risk factor: 56 years for patients with a family history, 59 years for those with many moles and 69 years for those with a previous melanoma.

Also, higher-risk patients with many moles were more likely to have melanoma on the trunk, those with a family history were more likely to have melanomas on the limbs, and those with a personal history were more likely to have melanoma on the head and neck.

Ipilimumab Combined With Local Treatments Improve Survival for Melanoma Patients
Local peripheral treatments are not used to cure patients with malignant melanoma; rather, they are used to provide relief from symptoms caused by the melanoma.

Limitations of the study include risk factors based on physician recall and patient medical records. The authors also did not assess the reliability or validity of the risk factor data.

"The results of our study suggest that a person's risk factor status might be used to tailor their surveillance program in terms of starting age and education about skin self-examination or more intensive surveillance," the study concludes.

N-Acetyl Cysteine Improves Effectiveness for Melanoma
Culturing T cells in N-acetyl cysteine (NAC) before they are infused as immunotherapy improves effectiveness and outcomes in a preclinical model of melanoma.

The study is published in JAMA Dermatology.

Source-Eurekalert

For Treating Advanced Melanoma, New Cancer Drug Shows Promise
Researchers report that a new drug in preliminary tests has shown promising results with very manageable side effects for treating patients with melanoma, the deadliest form of skin cancer.